The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention
Open accessAbstract
OBJECTIVES The aim of this study was to assess whether small creatine kinase-MB isoenzyme (CK-MB) elevations after percutaneous coronary intervention (PCI) affect the subsequent mortality risk. BACKGROUND Several studies have evaluated the relationship of CK-MB levels after PCI with the subsequent risk of death. While there is consensus that elevations exceeding 5 times the upper limit of normal increase mortality significantly, there is uncertainty about the exact clinical impact of smaller CK-MB elevations. METHODS We performed a meta-analysis of seven studies with CK-MB measurements and survival outcomes on 23230 subjects who underwent PCI. Data were combined with random effects models. RESULTS Mean follow-up was 6 to 34 months per study. By random effects, 19% (95% confidence interval [CI], 16% to 23%) had one- to five-fold CK-MB elevations, while only 6% (95% CI, 5% to 9%) had >5-fold elevations. Compared with subjects with normal CK-MB, there was a dose-response relationship with relative risks for death being 1.5 (95% CI, 1.2 to 1.8, no between-study heterogeneity) with one- to three-fold CK-MB elevations, 1.8 (95% CI, 1.4 to 2.4, no between-study heterogeneity) with three- to five-fold CK-MB elevations, and 3.1 (95% CI, 2.3 to 4.2, borderline between-study heterogeneity) with over five-fold CK-MB elevations (p < 0.001 for all). CONCLUSIONS Any increase in CK-MB after PCI is associated with a small, but statistically and clinically significant, increase in the subsequent risk of death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antman, E., Bassand, J.-P., Klein, W., Ohman, M., Lopez Sendon, J. L., Rydén, L., Simoons, M., & Tendera, M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00804-4 · Cited by 4,821
Alpert, J. S., Thygesen, K. A., Antman, E. M., & Bassand, J. (2001) · Journal of the American College of Cardiology · Cited by 1,282
Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis
Petitti, D. B. (1999) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195133646.001.0001 · Cited by 925
Recognition of the Importance of Embolization in Atherosclerotic Vascular Disease
Topol, E. J., & Yadav, J. S. (2000) · Circulation · doi:10.1161/01.cir.101.5.570 · Cited by 770
Myonecrosis After Revascularization Procedures
Califf, R. M., Abdelmeguid, A. E., Kuntz, R. E., Popma, J. J., Davidson, C. J., Cohen, E. A., Kleiman, N. S., Mahaffey, K. W., Topol, E. J., Pepine, C. J., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00506-8 · Cited by 552
Prognostic Implication of Creatine Kinase Elevation Following Elective Coronary Artery Interventions
Kong, T. Q. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540300029029 · Cited by 283
Tardiff, B. E., Califf, R. M., Tcheng, J. E., Lincoff, A. M., Sigmon, K. N., Harrington, R. A., Mahaffey, K. W., Ohman, E. M., Teirstein, P. S., Blankenship, J. C., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00551-8 · Cited by 217
Ellis, S. G., Chew, D., Chan, A., Whitlow, P. L., Schneider, J. P., & Topol, E. J. (2002) · Circulation · doi:10.1161/01.cir.0000028146.71416.2e · Cited by 209
Brener, S. J., Lytle, B. W., Schneider, J. P., Ellis, S. G., & Topol, E. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02538-x · Cited by 179
Karvouni, E., Katritsis, D. G., & Ioannidis, J. P. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02666-9 · Cited by 173
Self-citation
Cited by
Universal Definition of Myocardial Infarction
Thygesen, K., Alpert, J. S., White, H. D., TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), J. S. A. (., Biomarker Group: Allan S. Jaffe, C. (., ECG Group: Bernard Chaitman, C.-O. (., Imaging Group: Richard Underwood, C. (., Intervention Group: Jean-Pierre Bassand, C.-O. (., Clinical Investigation Group: Paul W. Armstrong, C. (., Global Perspective Group: Philip A. Poole-Wilson, C. (., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.187397 · Cited by 4,230
Task Force Members, Thygesen, K., Alpert, J. S., White, H. D., Biomarker Group, Jaffe, A. S., Apple, F. S., Galvani, M., Katus, H. A., Newby, L. K., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm355 · Cited by 2,541
Universal Definition of Myocardial Infarction
Thygesen, K., Alpert, J. S., & White, H. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.011 · Cited by 1,618
Moussa, I. D., Klein, L. W., Shah, B., Mehran, R., Mack, M. J., Brilakis, E. S., Reilly, J. P., Zoghbi, G., Holper, E., & Stone, G. W. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.720 · Cited by 650
UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION
Thygesen, K., Alpert, J., & White, H. (2008) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2008-4-5-91-105 · Cited by 525
Metadata
- Authors
- Ioannidis, J. P. A., Karvouni, E., & Katritsis, D. G.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2003-10
- Volume
- 42
- Issue
- 8
- Pages
- 1406-1411
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2153379012
- Cited by
- 254
- References
- 15
- FWCI
- 8.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. https://app.cochat.ai/papers/10.1016/s0735-1097(03)01044-1
- The paper
- Ioannidis, J. P. A., Karvouni, E., & Katritsis, D. G. (2003). Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. Journal of the American College of Cardiology. https://doi.org/10.1016/s0735-1097(03)01044-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.